Occult hepatitis B virus coinfection in HIV‐positive African migrants to the UK: a point prevalence study Journal Articles uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

abstract

  • ObjectivesOccult (surface antigen‐negative/DNA‐positive) hepatitis B virus (HBV) infection is common in areas of the world where HBV is endemic. The main objectives of this study were to determine the prevalence of occult HBV infection in HIV‐infected African migrants to the UK and to determine factors associated with occult coinfection.MethodsThis anonymized point‐prevalence study identified Africans attending three HIV clinics, focussing on patients naïve to antiretroviral therapy (ART). Stored blood samples were tested for HBV DNA. Prevalence was calculated in the entire cohort, as well as in subpopulations. Risk factors for occult HBV coinfection were identified using logistic regression analysis.ResultsAmong 335 HIV‐positive African migrants, the prevalence of occult HBV coinfection was 4.5% [95% confidence interval (CI) 2.8–7.4%] overall, and 6.5% (95% CI 3.9–10.6%) and 0.8% (95% CI 0.2–4.6%) in ART‐naïve and ART‐experienced patients, respectively. Among ART‐naïve anti‐HBV core (anti‐HBc)‐positive patients, the prevalence was 16.4% (95% CI 8.3–25.6%). The strongest predictor of occult coinfection was anti‐HBc positivity [odds ratio (OR) 7.4; 95% CI 2.0–27.6]. Median HBV DNA and ALT levels were 54 IU/mL [interquartile range (IQR) 33–513 IU/mL] and 22 U/L (IQR 13–27 U/L), respectively.ConclusionsOccult HBV coinfection remains under‐diagnosed in African HIV‐infected patients in the UK. Given the range of HBV DNA levels observed, further studies are warranted to determine its clinical significance and to guide screening strategies and ART selection in these patients.

authors

  • Chadwick, D
  • Doyle, T
  • Ellis, S
  • Price, David
  • Abbas, I
  • Valappil, M
  • Geretti, AM

publication date

  • March 2014